A detailed history of Horan Capital Advisors, Llc. transactions in Pfizer Inc stock. As of the latest transaction made, Horan Capital Advisors, Llc. holds 7,209 shares of PFE stock, worth $189,164. This represents 0.07% of its overall portfolio holdings.

Number of Shares
7,209
Previous 7,209 -0.0%
Holding current value
$189,164
Previous $201,000 3.48%
% of portfolio
0.07%
Previous 0.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $3,883 - $4,459
150 Added 2.12%
7,209 $200,000
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $2,926 - $3,801
-112 Reduced 1.56%
7,059 $203,000
Q3 2023

Nov 01, 2023

SELL
$32.09 - $37.51 $33,181 - $38,785
-1,034 Reduced 12.6%
7,171 $237,000
Q3 2022

Nov 01, 2022

SELL
$43.76 - $53.42 $4,813 - $5,876
-110 Reduced 1.32%
8,205 $359,000
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $13,307 - $15,778
-286 Reduced 3.33%
8,315 $436,000
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $53,847 - $66,724
1,177 Added 15.85%
8,601 $445,000
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $12,396 - $18,375
300 Added 4.21%
7,424 $438,000
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $7,850 - $10,084
-200 Reduced 2.73%
7,124 $306,000
Q1 2021

May 05, 2021

SELL
$33.49 - $37.77 $30,375 - $34,257
-907 Reduced 11.02%
7,324 $265,000
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $62,957 - $80,055
1,881 Added 29.62%
8,231 $303,000
Q1 2020

Apr 29, 2020

SELL
$27.03 - $38.62 $65,277 - $93,267
-2,415 Reduced 27.55%
6,350 $207,000
Q3 2019

Oct 22, 2019

SELL
$32.49 - $42.13 $5,685 - $7,372
-175 Reduced 1.96%
8,765 $315,000
Q1 2019

Apr 22, 2019

BUY
$37.5 - $41.2 $47,362 - $52,035
1,263 Added 16.45%
8,940 $380,000
Q4 2018

Feb 04, 2019

BUY
$38.47 - $43.86 $25,197 - $28,728
655 Added 9.33%
7,677 $335,000
Q3 2018

Nov 02, 2018

BUY
$34.47 - $41.81 $26,541 - $32,193
770 Added 12.32%
7,022 $309,000
Q2 2018

Sep 13, 2018

BUY
$32.98 - $35.16 $153,192 - $163,318
4,645 Added 289.05%
6,252 $227,000
Q2 2018

Jul 31, 2018

SELL
$32.98 - $35.16 $210,907 - $224,848
-6,395 Reduced 79.92%
1,607 $60,000
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $12,638 - $13,410
-380 Reduced 4.53%
8,002 $290,000
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $259,842 - $286,245
8,382
8,382 $299,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Horan Capital Advisors, Llc. Portfolio

Follow Horan Capital Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Capital Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Capital Advisors, Llc. with notifications on news.